348 related articles for article (PubMed ID: 22939943)
21. Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice.
Liu W; Wang Z; Yang J; Wang Y; Li K; Huang B; Yan B; Wang T; Li M; Zou Z; Yang J; Xiao G; Cui ZK; Liu A; Bai X
Open Biol; 2019 May; 9(5):180262. PubMed ID: 31088250
[TBL] [Abstract][Full Text] [Related]
22. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging.
Davis HM; Pacheco-Costa R; Atkinson EG; Brun LR; Gortazar AR; Harris J; Hiasa M; Bolarinwa SA; Yoneda T; Ivan M; Bruzzaniti A; Bellido T; Plotkin LI
Aging Cell; 2017 Jun; 16(3):551-563. PubMed ID: 28317237
[TBL] [Abstract][Full Text] [Related]
23. Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone.
Xiong J; Piemontese M; Onal M; Campbell J; Goellner JJ; Dusevich V; Bonewald L; Manolagas SC; O'Brien CA
PLoS One; 2015; 10(9):e0138189. PubMed ID: 26393791
[TBL] [Abstract][Full Text] [Related]
24. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations.
Kennedy OD; Herman BC; Laudier DM; Majeska RJ; Sun HB; Schaffler MB
Bone; 2012 May; 50(5):1115-22. PubMed ID: 22342796
[TBL] [Abstract][Full Text] [Related]
25. Pulsed electromagnetic fields regulate osteocyte apoptosis, RANKL/OPG expression, and its control of osteoclastogenesis depending on the presence of primary cilia.
Wang P; Tang C; Wu J; Yang Y; Yan Z; Liu X; Shao X; Zhai M; Gao J; Liang S; Luo E; Jing D
J Cell Physiol; 2019 Jul; 234(7):10588-10601. PubMed ID: 30422320
[TBL] [Abstract][Full Text] [Related]
26. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption.
Tan SD; de Vries TJ; Kuijpers-Jagtman AM; Semeins CM; Everts V; Klein-Nulend J
Bone; 2007 Nov; 41(5):745-51. PubMed ID: 17855178
[TBL] [Abstract][Full Text] [Related]
27. Osteocyte-driven bone remodeling.
Bellido T
Calcif Tissue Int; 2014 Jan; 94(1):25-34. PubMed ID: 24002178
[TBL] [Abstract][Full Text] [Related]
28. Irradiation-induced osteocyte damage promotes HMGB1-mediated osteoclastogenesis in vitro.
He F; Bai J; Wang J; Zhai J; Tong L; Zhu G
J Cell Physiol; 2019 Aug; 234(10):17314-17325. PubMed ID: 30786022
[TBL] [Abstract][Full Text] [Related]
29. Role of osteocytes in multiple myeloma bone disease.
Delgado-Calle J; Bellido T; Roodman GD
Curr Opin Support Palliat Care; 2014 Dec; 8(4):407-13. PubMed ID: 25289928
[TBL] [Abstract][Full Text] [Related]
30. RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice.
Fujiwara Y; Piemontese M; Liu Y; Thostenson JD; Xiong J; O'Brien CA
J Biol Chem; 2016 Nov; 291(48):24838-24850. PubMed ID: 27733688
[TBL] [Abstract][Full Text] [Related]
31. RANKL as the master regulator of osteoclast differentiation.
Takayanagi H
J Bone Miner Metab; 2021 Jan; 39(1):13-18. PubMed ID: 33385253
[TBL] [Abstract][Full Text] [Related]
32. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W
J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919
[TBL] [Abstract][Full Text] [Related]
33. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
[TBL] [Abstract][Full Text] [Related]
34. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of RANKL delivery to the osteoclast precursor cell surface.
Honma M; Ikebuchi Y; Suzuki H
J Bone Miner Metab; 2021 Jan; 39(1):27-33. PubMed ID: 33047191
[TBL] [Abstract][Full Text] [Related]
36. Osteocytes and Paget's Disease of Bone.
Tenshin H; Delgado-Calle J; Windle JJ; Roodman GD; Chirgwin JM; Kurihara N
Curr Osteoporos Rep; 2024 Apr; 22(2):266-272. PubMed ID: 38457001
[TBL] [Abstract][Full Text] [Related]
37. Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.
Azab E; Chandler KB; Uda Y; Sun N; Hussein A; Shuwaikan R; Lu V; Costello CE; McComb ME; Divieti Pajevic P
FASEB J; 2020 Aug; 34(8):10191-10211. PubMed ID: 32557809
[TBL] [Abstract][Full Text] [Related]
38. The Differential Effect of Metformin on Osteocytes, Osteoblasts, and Osteoclasts.
de Vries TJ; Kleemann AS; Jin J; Schoenmaker T
Curr Osteoporos Rep; 2023 Dec; 21(6):743-749. PubMed ID: 37796390
[TBL] [Abstract][Full Text] [Related]
39. Evidence for osteocyte regulation of bone homeostasis through RANKL expression.
Nakashima T; Hayashi M; Fukunaga T; Kurata K; Oh-Hora M; Feng JQ; Bonewald LF; Kodama T; Wutz A; Wagner EF; Penninger JM; Takayanagi H
Nat Med; 2011 Sep; 17(10):1231-4. PubMed ID: 21909105
[TBL] [Abstract][Full Text] [Related]
40. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
